The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Metabolic Guidelines ArticleArticle on the recent metabolic guidelines by Peter Haddad, Gavin Reynolds and Stephen Cooper
Dementia Guidelines MeetingClinical Practice with Anti-Dementia Drugs: Updated Guidelines from the BAP, 19th January 2017
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
New world order: Brexit, drugs and researchLetter to House of Commons Science and Technology Committee
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Ketamine SchedulingBAP endorses the Fact Sheet on Ketamine Scheduling
Psychoactive Substances BillThe BAP response to the proposed bill
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|4th November 2016||Translational Neuroscience and Mental Disorders||Ettore Majorana Foundation and Centre for Scientific Culture, Via Guarnotta, 26, ITALY|
|15th November 2016||Perinatal and Infant Mental Health: Intrinsic Links and Integrated Strategies Conference||Pen Green Conference Centre, Corby|
|17th November 2016||Child and Adolescent Psychopharmacology||Vista Suite, Park Plaza Hotel, Maid Marian Way, Nottingham|
It's okay to talk this world suicide prevention day
Andrew talks to Dorset Eye about how suicide affects everybody
7th September 2016
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses
Will Lawn and colleagues have published a paper about cannabis and motivation, covered in The Times and Independent newspapers.
2nd September 2016
Mental Health is...Mental
Stephen was at the Edinburgh Fringe arguing that words like Mental and phrases like Mental Health are best avoided, and that talking about the Stigma of Mental Health/Illness is itself stigmatising.
4th August 2016
|Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry |
12th September 2016
The Fundamentals of Clinical Psychopharmacology has won the BMA Medical Book Award in Psychiatry
|New world order: Brexit, drugs and research |
12th August 2016
Oliver Howes wrote to House of Commons Science and Technology Committee to raise issues on behalf of the BAP following the Brexit vote.
Read BAP letter to Nicola Blackwood
|NIHR Research funding opportunity |
27th July 2016
NIHR research funding opportunities for the Health Technology Assessment (HTA) programme
View funding opportunties
|Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology |
13th April 2016
Journal of Psychopharmacology chosen to trial new Neuroscience-based Nomenclature (NbN).